🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 29 of 78

  1. US 9757425

    Method and composition for synchronizing time of insemination

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9750793

    Multifunctional oral vaccine based on chromosome recombineering

    Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9751931

    Hepatitis C virus neutralizing antibodies and methods

    Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9744226

    Attenuated Mannheimia haemolytica strains

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9738726

    HER2-specific monoclonal antibodies and conjugates thereof

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9737478

    Treatment of malaria

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9738703

    Neutralizing antibodies to HIV-1 and their use

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9730993

    Engineered anthrax lethal toxin for targeted delivery

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9730911

    Cannabis extracts and methods of preparing and using same

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9732337

    RNA nanoparticles and nanotubes

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9732359

    Replication-competent adenoviral vectors

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9730941

    Methods and compositions for the inhibition of Pin1

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9725494

    Soluble CD27 (sCD27) and the use thereof

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9725492

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9724376

    Olive leaf powder

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9724380

    Method and compositions for synchronizing time of insemination in gilts

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9717752

    Uses of antagonists of hyaluronan signaling

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9719080

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9713599

    Parenteral formulations of treprostinil

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9713600

    Method for treating metabolic syndrome

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9707199

    Heptadecanoic acid supplement to human diet

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9707289

    Biochemically stabilized HIV-1 ENV trimer vaccine

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9707220

    Scopolamine for the treatment of depression and anxiety

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9708392

    Monoclonal antibodies against orthopoxviruses

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9707283

    Genetically modified babesia parasites expressing protective tick antigens and uses thereof

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9707287

    Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9708267

    Activators of human pyruvate kinase

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9707230

    Activators of human pyruvate kinase

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9701718

    Adenovirus serotype 26 and serotype 35 filovirus vaccines

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9701740

    Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9700562

    Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9700578

    Use of nitrite salts for the treatment of cardiovascular conditions

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9701611

    Salts of treprostinil

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9694062

    Plasmodium falciparum sporozoite and liver stage antigens

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9695230

    Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9688739

    T cell receptors and related materials and methods of use

    Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9687461

    Method for detecting risk factor for metabolic syndrome or hyperferritinemia

    Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9687542

    Rift valley fever virus replicon particles and use thereof

    Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9683269

    Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9683024

    Recombinantly expressed plasmodium CelTOS antigen and methods of use thereof

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9683263

    Detection and treatment of irritable bowel syndrome

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9682116

    Date pit composition for the treatment of animals

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9682107

    Postnatal stem cells and uses thereof

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9682088

    Method for treating uterine fibroids

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9675554

    Method of forming liposomes

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9676771

    Compounds for inhibiting drug-resistant strains of HIV-1 integrase

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9676846

    Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9675572

    Intravenous omega-3 fatty acid compositions and method of use

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.